Characteristics | Patients | CD68 expression | CD163 expression | |||||
---|---|---|---|---|---|---|---|---|
NO. | % | Low | High | P | Low | High | P | |
Gender | ||||||||
 Female | 105 | 47.5 | 70 | 35 | 0.217 | 62 | 43 | 0.222 |
 Male | 116 | 52.5 | 68 | 48 |  | 59 | 57 |  |
Age (years) | ||||||||
 ≤ 60 | 130 | 58.8 | 87 | 43 | 0.100 | 73 | 57 | 0.617 |
 >60 | 91 | 41.2 | 51 | 40 |  | 48 | 43 |  |
ECOG-PS | ||||||||
 ≤ 1 | 136 | 61.5 | 98 | 38 | <0.001 | 83 | 53 | 0.018 |
 >1 | 85 | 38.5 | 40 | 45 |  | 38 | 47 |  |
Extranodal sites of disease | ||||||||
 ≤ 1 | 176 | 79.6 | 117 | 59 | 0.014 | 103 | 73 | 0.026 |
 >1 | 45 | 20.4 | 21 | 24 |  | 18 | 27 |  |
Ann Arbor stage | ||||||||
 I/II | 127 | 57.5 | 93 | 34 | <0.001 | 80 | 47 | 0.004 |
 III/IV | 94 | 42.5 | 45 | 49 |  | 41 | 53 |  |
LDH | ||||||||
 ≤ normal | 159 | 71.9 | 114 | 45 | <0.001 | 103 | 56 | <0.001 |
 >normal | 62 | 28.1 | 24 | 38 |  | 18 | 44 |  |
IPI score | ||||||||
 0–2 | 154 | 69.7 | 114 | 40 | <0.001 | 98 | 56 | <0.001 |
 3–5 | 67 | 30.3 | 24 | 43 |  | 23 | 44 |  |
AMC | ||||||||
 <460/ul | 118 | 53.4 | 88 | 30 | <0.001 | 82 | 36 | <0.001 |
 ≥ 460/ul | 103 | 46.6 | 50 | 53 |  | 39 | 64 |  |